endocrineus Landing page




Pfizer is proud to introduce 2016 US ASPIRE Investigator Research Awards in Endocrinology

As competition for research funding opportunities increases, the ASPIRE program underscores Pfizer's commitment to supporting exceptional investigators with an interest in advancing their academic research careers in Endocrinology.

Mission

The mission of the 2016 US ASPIRE Investigator Research Awards in Endocrinology is to advance the medical knowledge of the fundamental mechanisms of disease, mechanisms of action of current and potential future treatments, and to improve the care of patients with endocrine disorders.

The ASPIRE Program demonstrates Pfizer’s commitment to supporting exceptional investigators with an interest in advancing knowledge in defined disease areas of endocrinology.

Background

Scientific research continues to advance our knowledge and understanding of endocrine disorders and their treatments. The 2016 US ASPIRE Investigator Research Awards in Endocrinology is designed to:

  1. Support exceptional investigators working in the field of endocrinology.
  2. Advance the understanding of disease mechanisms or treatments through translational basic science or clinical research in order to enhance the clinical care of pediatric and adult patients with endocrine diseases.

Request for Proposals and Areas of Focus

Pfizer invites interested investigators to apply for the 2016 US ASPIRE Investigator Research Awards in Endocrinology. Funding will be provided to research proposals that seek to explore translational or clinical research in the following endocrinology areas:

  • Acromegaly in Adults
  • Growth Hormone Disorders in Children

Available Awards

Pfizer is funding 1 award of up to $100,000 over 2 years to conduct basic science, translational or clinical research generating data that will help advance the science of acromegaly in adults and 1 award of up to $75,000 over 2 years to conduct basic science, translational or clinical research generating data that will help advance the science of growth hormone disorders in children.